
    
      An open-label, randomised, crossover, drug interaction study. Subjects were divided into
      three groups and within each group, subjects were randomised to one of two treatment
      sequences. Subjects received 4 sprays of Sativex alongside either doses of rifampicin,
      ketoconazole or omeprazole.
    
  